tiprankstipranks
Trending News
More News >
Kose Corporation (JP:4922)
:4922
Advertisement

Kose (4922) AI Stock Analysis

Compare
2 Followers

Top Page

JP:4922

Kose

(4922)

Select Model
Select Model
Select Model
Neutral 60 (OpenAI - 4o)
Rating:60Neutral
Price Target:
¥6,138.00
▲(1.35% Upside)
Kose's overall stock score is primarily influenced by its strong financial stability and robust balance sheet, which are offset by declining net profitability and cash flow challenges. The technical analysis indicates a lack of strong momentum, and the high P/E ratio suggests overvaluation. These factors collectively result in a moderate stock score.

Kose (4922) vs. iShares MSCI Japan ETF (EWJ)

Kose Business Overview & Revenue Model

Company DescriptionKose Corporation (4922) is a leading Japanese cosmetics and skincare company that specializes in the development, manufacturing, and marketing of a wide range of beauty products. Founded in 1946, Kose operates primarily in the cosmetics sector, offering products across various categories, including skincare, makeup, and hair care. The company's portfolio includes well-known brands such as Sekkisei, Esprique, and Jill Stuart, catering to both domestic and international markets.
How the Company Makes MoneyKose generates revenue through multiple streams, primarily by selling its beauty and skincare products through various distribution channels, including department stores, drugstores, and online platforms. The company's strong brand recognition and wide product range allow it to capture a diverse customer base, contributing significantly to its sales. Additionally, Kose engages in strategic partnerships with retailers and distributors to expand its market reach and enhance its product visibility. The company also invests in research and development to innovate new products and improve existing ones, thus driving consumer interest and sales. Revenue is further bolstered by seasonal promotions and marketing campaigns that enhance brand appeal and drive purchases.

Kose Financial Statement Overview

Summary
Kose demonstrates strong revenue growth and gross profitability, alongside a robust balance sheet with minimal leverage. However, there's a downward trend in net profitability and challenges in free cash flow sustainability. While the company is financially stable with low debt, improving net margins and addressing cash flow issues will be crucial for long-term growth.
Income Statement
75
Positive
Kose experienced a moderate revenue growth of 7.42% from 2023 to 2024, but this was lower compared to its growth in previous years. The gross profit margin for 2024 was 68.95%, indicating strong profitability in production. However, the net profit margin decreased to 2.33% in 2024 from 3.88% in 2023, signaling a decline in net profitability. The EBITDA margin was 9.15%, showing stable operational efficiency, though it has decreased compared to previous periods. Overall, Kose's income statement reflects strong revenue growth and gross profitability, but declining net profitability poses a risk.
Balance Sheet
80
Positive
Kose's balance sheet remains robust with an equity ratio of 71.05% in 2024, indicating strong financial stability and low reliance on debt. The debt-to-equity ratio is very low at 0.04, showing minimal leverage. The return on equity was 2.76% for 2024, indicating a decrease in profitability from equity compared to previous years. Kose's financial position is stable, with excellent equity health and low debt levels, though there's room for improvement in equity returns.
Cash Flow
60
Neutral
The cash flow statement shows a significant decline in free cash flow from 2023 to 2024, turning negative at -2.67 billion, reflecting potential issues in cash generation. The operating cash flow to net income ratio is strong at 2.45, indicating good cash generation from operations relative to net income. However, the free cash flow to net income ratio is negative, highlighting potential cash flow challenges. Overall, Kose's cash flow statement indicates strong operational cash flows but highlights concerns over free cash flow sustainability.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue324.17B322.76B300.41B289.14B299.98B279.39B
Gross Profit223.08B222.57B211.20B205.51B204.15B201.92B
EBITDA28.03B29.55B30.10B38.63B39.70B30.68B
Net Income5.86B7.51B11.66B18.77B17.79B11.99B
Balance Sheet
Total Assets377.27B383.12B371.66B359.60B320.02B308.39B
Cash, Cash Equivalents and Short-Term Investments98.56B113.97B132.85B116.53B105.28B103.39B
Total Debt10.39B11.22B10.21B9.98B1.42B8.53B
Total Liabilities88.67B92.49B88.62B84.25B65.75B67.09B
Stockholders Equity270.38B272.30B266.16B258.99B238.36B225.50B
Cash Flow
Free Cash Flow0.00-2.67B24.92B13.16B12.99B12.54B
Operating Cash Flow0.0018.38B30.44B20.26B17.80B23.28B
Investing Cash Flow0.00-8.93B-11.23B-6.31B-4.72B-5.85B
Financing Cash Flow0.00-8.68B-9.68B-7.31B-14.30B-7.36B

Kose Technical Analysis

Technical Analysis Sentiment
Positive
Last Price6056.00
Price Trends
50DMA
5892.88
Positive
100DMA
5831.73
Positive
200DMA
5978.84
Positive
Market Momentum
MACD
14.79
Positive
RSI
54.68
Neutral
STOCH
39.71
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4922, the sentiment is Positive. The current price of 6056 is above the 20-day moving average (MA) of 5946.75, above the 50-day MA of 5892.88, and above the 200-day MA of 5978.84, indicating a bullish trend. The MACD of 14.79 indicates Positive momentum. The RSI at 54.68 is Neutral, neither overbought nor oversold. The STOCH value of 39.71 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4922.

Kose Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
$563.45B16.0713.33%1.70%15.90%13.60%
71
Outperform
¥151.48B19.925.07%1.41%0.75%
68
Neutral
$297.77B46.336.05%3.91%-1.16%36.30%
66
Neutral
$419.99B20.499.77%1.85%2.18%60.81%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
60
Neutral
$345.44B115.342.72%2.37%1.37%-5.60%
56
Neutral
¥1.05T-808.821.93%-3.60%-112.93%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4922
Kose
6,056.00
-821.12
-11.94%
JP:4912
Lion
1,570.50
-161.58
-9.33%
JP:4927
Pola Orbis Holdings
1,320.50
3.26
0.25%
JP:4527
Rohto Pharmaceutical Co
2,415.00
-924.89
-27.69%
JP:4911
Shiseido Company,Limited
2,585.50
-232.92
-8.26%
JP:4928
Noevir Holdings Co., Ltd.
4,525.00
-209.33
-4.42%

Kose Corporate Events

KOSÉ Corporation Reports Mixed Financial Results
Aug 8, 2025

KOSÉ Corporation is a leading Japanese company in the cosmetics industry, known for its innovative beauty products and strong presence in both domestic and international markets. The company operates primarily in the cosmetics and cosmetaries sectors, offering a wide range of skincare, makeup, and personal care products.

KOSÉ Corporation Reports Decline in Profits Despite Increased Sales
Aug 7, 2025

KOSÉ Corporation reported its financial results for the second quarter of fiscal year 2025, showing a slight increase in net sales by 0.9% compared to the previous year. However, there was a significant decline in operating profit, ordinary profit, and profit attributable to owners of the parent, with decreases of 17.7%, 49.1%, and 38.9% respectively. The company’s comprehensive income also dropped by 86.7%. Despite these declines, the equity ratio improved to 73.3%, indicating a stronger financial position. The company maintained its dividend forecast and did not revise its consolidated forecast for the full year of 2025.

The most recent analyst rating on (JP:4922) stock is a Hold with a Yen7000.00 price target. To see the full list of analyst forecasts on Kose stock, see the JP:4922 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 30, 2025